In a few short weeks, Blue Matter team members will be attending the annual meeting of the American Society of Clinical Oncology (ASCO). Let's connect there! Attending team members: Pankaj Oza, Tahel Noy, Shankar Sundar, & Mary Lee Learn more: https://lnkd.in/eAiKEdE #ASCO24 #cancerresearch #oncology #biotech #pharmaceuticals
Blue Matter’s Post
More Relevant Posts
-
Principal - Oncology - Oracle Life Sciences | Consulting | Commercialization | Research | RWE Data & Analytics
An Exploration of Oncology Development: 2023 in review DOWNLOAD this interactive PDF to see how biopharma is reshaping the future of cancer care, with an interactive (and fun!) focus on novel drugs, key trial outcomes, and regulatory events of the past year. #biotech #pharmaceuticals #oncology #cancermpact https://lnkd.in/gi58WGyf
-
BioPharma Practice Leader | Market Access | BD, Licensing & Partnerships | Commercial Strategy | Research & Analysis | Strategic Intelligence |
I look forward to attending the sessions lined up for today. The topics are wide ranging and covers from brain metasteses to urothelial, and advances in IO among others. EOS Intelligence ESMO - European Society for Medical Oncology #competitiveintelligence #marketaccess #marketresearch #oncology #pharmaceuticals #biotech
-
-
Experienced Global Scientific Business Leader | Diagnostic Consultant | Supporting precision medicines and diagnostics for the benefit of patients!
Looking forward to sharing some of our latest advances with solid tumor predictive response signatures in tissue and now #liquidbiopsy #precisionmedicine #oncology #diagnostics
We’ll be at the American Association for Cancer Research Annual Meeting next week in San Diego. Please contact Brian Kelly or [email protected] to meet with our team and learn more about our novel RNA-based diagnostics for oncology. #AACR24 #precisionmedicine #biotechnology #pharmaceuticals
-
-
As the field of immuno-oncology continues to grow, it is crucial to adopt advanced tools for more accurate and efficient drug development. Cell-based assays are a promising approach that can lead to the development of more effective and safer drugs. Read this Editorial article and learn more about the latest advances in cell-based assays in immuno-oncology from Dr. Peter Betz Wolff (Implementation Scientist at AGC Biologics) https://hubs.ly/Q01WdkmC0 #immunooncology #cancer #cancerresearch #oncology #DrugDiscovery #Pharma #Therapeutics #answersinlifescience #expertpartner #partnerwithus
-
-
Speed to data Speed to fail vs. win compounds Speed to a stronger candidate selection Speed to an efficiently designed clinical development program Add speed to your oncology drug discovery efforts with Predictive Oncology How much faster can you generate data to support the candidate with the highest probability of clinical success? https://lnkd.in/g2KPaUHy #drugdiscovery #drugdevelopment #pharma #emergingtechnologies #biopharma #molecularbiology #oncologydrugdiscovery #oncology #machinelearning #AI #marketaccess #artificialintelligence #digitaltransformation #cancerresearch #biotech #lifesciences
-
-
Today in The Agenda, FirstWord Edge's daily briefing, we cover: What next for IO in #lungcancer? 🫁 Leading KOL provides lowdown on the state of play for IO in #NSCLC 🔬 Assessing iTeos Therapeutics non-TIGIT ambitions 📊 Digging deeper into US/European RCC treatment trends & attitudes ➕ Cancer licensing deals/collaborative agreements of note Learn how you can gain access to this content ➡️ https://lnkd.in/eCQmbCgx #oncology #pharmaceuticals #biotechnology #news #insights
-
Check out the latest insights from our #Oncology experts! 👇🏼
It seems that 2023 was the year of the ADC (antibody-drug conjugates), with news about the modality being ever-present. However, that was not always the case. In this new Ipsos POV, Eric Blouin and Adam Kaufman, MBA dive into the early history of ADCs, how the class evolved, and and where we are today – and expect to be tomorrow. #oncology #cancer #cancerresearch #biopharma #pharmaceutical #adc